Ask a VC for a $20M valuation on a $3M seed and you've just promised them a $620M exit.

Exit value implied by different seed valuations

Most founders don't know they made that promise. The investor does.

Founders treat valuation as a debate about what the company is worth. VCs treat it as a calculation of what the company has to become.

That gap is where most first negotiations go wrong. The founder argues about today; the investor is pricing the exit, the fund and the next three rounds.

This guide puts you on the investor's side of the table, with the numbers, so you can negotiate with their math instead of against it.

Below is the full breakdown, built around one fictional startup, plus a 45-minute negotiation prep at the end.

1. The Napkin Math: How a VC Turns Your Exit Into Today's Price

Most founders think a valuation is a verdict on how good the company is. It isn't. It's the output of a short calculation that starts at the end: the day the company is sold.

Meet Lumen, a fictional B2B software startup raising a $3M seed. The lead investor believes Lumen could sell for $400M in seven years. With those two numbers, the VC runs four steps:

  1. The return they need. Investors in start-ups typically target 50% to 70% a year, according to Aswath Damodaran's teaching tables at NYU Stern. At 50% a year for seven years, every $1 has to become $17.10.

  2. The money they need back. $3M × 17.1 = $51.3M at exit.

  3. The stake they need at exit. $51.3M out of a $400M sale is 12.8%.

  4. The stake they need today. Lumen will raise a Series A, B and C, and each round shrinks the seed investor's slice. At Carta's median dilution (18% at Series A, 14% at B, 10% at C), only 63.5% of today's stake survives. So the VC has to buy 12.8% ÷ 0.635 = 20.2% now.

$3M for 20.2% is a $14.9M post-money valuation, or roughly $12M pre-money.

Lumen's seed valuation calculated with the VC Method

The most telling detail is step 4, because it's the one founders skip. Leave out future dilution and the same math says Lumen is worth $20M. That's the number founders walk in with, and the gap the VC spends the meeting closing.

The math also runs in reverse, and that's how a VC reads your ask. At $20M pre-money, the VC only gets 13% of Lumen, which shrinks to about 8.3% by the exit. To turn $3M into $51.3M with 8.3%, Lumen has to sell for about $620M. If your plan can defend $620M, ask for $20M. If it defends $400M, expect the conversation to land near $12M.

→ Before you name a number, know the exit it promises. If your plan can't defend that exit, the number won't survive the partner meeting.

2. Why VCs Fight for Ownership, Not Valuation

Here's what most first-time founders miss: many VCs care more about the percentage they own than the price they pay.

The reason is fund math. Most startups in a fund return little or nothing, so a common rule in venture is that every investment needs a shot at returning the whole fund on its own. Take a $50M seed fund. If it still owns 10% of a company at the exit, that company has to sell for $500M just to give the fund its money back. If it owns 5%, the company has to sell for $1B.

Exit value required to return a fund at different stakes

That's why ownership targets exist, and why they barely move. Carta's Peter Walker points to fund ownership targets as the reason median seed dilution has stayed close to 20% for years. In 2025, the median US software seed round sold 19.5% of the company, per Carta. A 20% stake bought today becomes about 12.7% by the exit, which is exactly the range the fund needs.

What this means for you:

  • Size the round around the stake, not just the cash. A VC who needs 15% won't lead a $1M round at a $20M post-money (5%), even if they love the price. Asking for too little can disqualify you as fast as asking for too much.

  • Use the market as your anchor. Fewer than 10% of software seed rounds in 2025 sold 30% or more, per Carta. If an investor asks for a third of your company at seed, that's an outlier, not "the market."

  • Name your strategic angels early. Tell the lead who else you want in the round, so they size their check around it instead of squeezing the angels out.

  • Raising in Europe? Adjust the anchors. On Equidam's valuation platform, European early-stage companies were valued at about 0.45x their US peers on average from 2020 to 2025, and they raised with more revenue. US medians are a ceiling there, not a floor.

→ Agree on the stake first and the price second. Once both sides know roughly how much of the company is for sale, the valuation becomes arithmetic.

3. Why Two VCs Can Price the Same Startup Very Differently

Same company, same deck, two investors, two very different offers. That's normal, and it comes down to how each fund is built.

A $3M check as a share of funds of different sizes

Seed funds live and die by each check. A $3M check is 12% of a $25M fund, so these investors are price-sensitive, care about ownership and run the napkin math from section 1 carefully.

Large multi-stage funds often write small early checks for a different reason: the option to lead your Series A later. Andreessen Horowitz's speedrun program, for example, invests up to $1M per startup, a rounding error for a firm that manages tens of billions. For these investors the entry price barely moves their fund. Expect less haggling on valuation and more interest in pro rata rights, the right to invest again in your next round.

Then there's culture. Some firms pay up for competitive deals, because if the company wins big, a $10M or $20M entry price barely matters. Others hold the line on price and walk away, however much they like you.

How to tell which one you're talking to:

  • Check size against fund size. Divide their typical check by the size of their latest fund. A big share means a price-sensitive investor; a tiny one means an option buyer.

  • Whether they lead. A fund that leads sets the price and wants the ownership. A fund that follows takes the price someone else sets.

  • How they negotiated before. Ask two founders from their portfolio. You can't read a firm's discipline on price from its website.

→ Price-sensitive investors negotiate the number. Option buyers negotiate the relationship. Know which one is across the table before you counter.

4. Your Only Real Leverage: A Second Term Sheet, Before the No-Shop

There's no script, trick or spreadsheet that beats this: two offers on the table at the same time.

With one term sheet, you negotiate against the investor's patience. With two, the investors negotiate against each other, and the "standard terms" suddenly become flexible.

That leverage has an expiry date. Most term sheets include a binding "no-shop," or exclusivity, clause: once you sign, you can't talk to other investors while the lead finishes due diligence and the legal documents. Funds often ask for 45 to 60 days, according to Startup Company Lawyer, and founders who can't remove the clause often try to cap it at 30 days or less. Brad Feld, co-author of Venture Deals, has written that he binds his own no-shops to 30 to 45 days.

Fundraising leverage timeline through the no-shop period

How to get the second offer:

  • Build a long, targeted list. Match funds by stage, check size and sector before the first email, so every meeting is with someone who can actually lead your round.

  • Batch your first meetings. Pack them into two or three weeks so offers arrive close together instead of months apart.

  • Start the slowest firms first. Funds with partner meetings and investment committees take longer, so begin with them and bring everyone to a decision in the same window.

  • Negotiate the no-shop like any other term. Ask for 30 days, and for the clause to end automatically if the investor walks away.

→ Settle everything that matters before you sign the term sheet. After that, the only investor you can negotiate with is the one who already has exclusivity.

5. The Price Is Only Half the Deal

A strong valuation with the wrong terms can still pay you less than a lower price with clean ones.

Three things decide what the headline number is really worth: the liquidation preference (who gets paid first when the company is sold), the option pool (whether new employee shares come out of your stake before the round) and the board (who decides when and how you sell).

Here's how that plays out. Lumen gets two offers for the same $3M seed:

  • Offer A: $12M pre-money, 1x non-participating preference. The VC owns 20%. At the exit it takes either its $3M back or its 20%, whichever is higher.

  • Offer B: $17M pre-money, 2x participating preference. The VC owns 15%. At the exit it takes $6M off the top, then 15% of whatever is left.

What founders take home at a $40M exit under two term sheets

Sell Lumen for $40M and Offer A leaves common shareholders $32M. Offer B leaves them $28.9M: $6M goes to the VC first, then 15% of the remaining $34M. The higher price costs the founders $3.1M.

The most telling detail is where the two offers cross. Offer B only pays founders more above a sale of about $102M. Below that, the lower valuation is the better deal, so ask yourself honestly which side of $102M your plan sits on.

You don't need to master these terms before the first meeting. You do need to read them before you compare two offers, because that's where a higher price can quietly turn into a worse deal. If you'd rather not make that call alone, Enduring Founder Club members can talk their round through one-to-one with Pablo.

→ Compare offers by what you take home, not by the headline. Then negotiate the price.

What's next: the 45-minute prep. What "market" looks like at pre-seed, seed and Series A, the formula to test your own ask, a 5-minute way to compare term sheets by what you take home, word-for-word answers to the four hardest questions and a Claude prompt that plays the VC.

logo

Subscribe to PREMIUM to read the rest.

Become a paying subscriber of PREMIUM to get access to this post and other subscriber-only content.

Upgrade

Already a subscriber? Sign in

A subscription gets you:

  • Everything included in Plus.
  • Ongoing access to new AI agent templates and the full library.
  • Complete access to the investor database and pitch deck collection.
  • Save 75% compared with paying monthly.

Reply

Avatar

or to participate